Extended Treatment for Smoking Cessation
延长戒烟治疗
基本信息
- 批准号:8505434
- 负责人:
- 金额:$ 51.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:21 year oldAbstinenceAddressAdolescentAdultAirBehavioralBupropionCarbon MonoxideCellsCellular PhoneChronicClinical TrialsCocaine DependenceCognitiveCognitive TherapyComputersControlled StudyCounselingCountyCox Proportional Hazards ModelsDetectionDevelopmentDiseaseDrug AddictionEarly DiagnosisEligibility DeterminationEvent History AnalysisIntentionKnowledgeLogistic RegressionsMaintenanceMeasuresMediator of activation proteinModelingMonitorNicotineOpiate AddictionOutcomeOutcome MeasureParticipantPharmacotherapyPhasePopulation StudyPrevalenceProbabilityPublic HealthRandomizedRecommendationRelapseReportingResearchSamplingSelection BiasSmokeSmokerSmokingSocietiesSupportive careSurvival AnalysisTailTarget PopulationsTechniquesTechnologyTelephoneTimeTobaccoTreatment FailureWithholding TreatmentWorkWritingalcoholism therapybasecigarette smokingcravingdepressive symptomsdesigndisorder later incidence preventionexperiencefollow-upmeetingsnicotine patchopen labelprimary outcomepublic health relevancerapid detectionresponsesecondary outcomeself helpskills trainingsmoking cessationsuccesstreatment planningtreatment responsevarenicline
项目摘要
DESCRIPTION (provided by applicant): Research indicates that drug addictions are chronic, relapsing disorders requiring extended therapy and follow-up. However, only a few smoking cessation trials have examined the utility of extended therapy models. We propose to examine the efficacy of a multi-component extended cigarette smoking cessation treatment in promoting longer-term smoking abstinence. Adult smokers and adolescent smokers (18 - 21) years of age will serve as the target population for this study. A total of 400 smokers will be randomized. Treatment will include both open label and extended treatment phases. Open Label Treatment. All 400 smokers will receive nicotine patch (21mg), bupropion (300mg) and individualized cognitive and behavioral skills training (ST). Nicotine patches and bupropion will be provided for 10 weeks and cognitive behavior therapy (CBT) will be provided for 26 weeks. Those who fail to respond to bupropion and nicotine patch will be switched to varenicline through week 26. Those who relapse beyond week 10 will re-start bupropion and nicotine patch through week 26. Extended Treatment. Following open label treatment, half (n=200) will receive CBT from week 26 - week 52. CBT will include both therapist-directed and self-directed relapse prevention skills training. In addition, telephone counseling will be provided in conjunction with voicemail, computer and cell phone technology enabling monitoring of treatment plan implementation and early detection of smoking "slips" and rapid response by treatment staff. Control. Remaining participants (n=200) will receive monthly telephone support calls from week 26 - week 52. The proposed study will address several important gaps in our knowledge of effective smoking cessation treatment. First, this will be one of only a handful of studies to investigate the effects of extended therapy for smoking cessation. Second, this will be among the first controlled studies to examine the effects of a multi-component treatment employing pharmacotherapy, intensive behavioral skills training, self-help skills training and rapid slip detection and response via voicemail, cell phone and telephone counseling.
描述(由申请人提供):研究表明,药物成瘾是一种慢性、复发性疾病,需要长期治疗和随访。然而,只有少数戒烟试验检验了扩展治疗模式的效用。我们建议检验多组分延长戒烟治疗在促进长期戒烟方面的功效。成年吸烟者和青少年吸烟者(18 - 21岁)将作为本研究的目标人群。总共400名吸烟者将被随机抽取。治疗将包括开放标签和延长治疗阶段。开放标签治疗。所有400名吸烟者将接受尼古丁贴片(21毫克)、安非他酮(300毫克)和个性化认知和行为技能训练(ST)。提供尼古丁贴片和安非他酮10周,提供认知行为治疗(CBT) 26周。那些对安非他酮和尼古丁贴片没有反应的人将在26周内改用伐尼克兰。那些在第10周后复发的人将在第26周重新开始服用安非他酮和尼古丁贴片。延长治疗。在开放标签治疗后,一半(n=200)将从第26周开始接受CBT治疗。CBT将包括治疗师指导和自我指导的复发预防技能培训。此外,还将提供电话咨询,并结合语音信箱、电脑和手机技术,监测治疗计划的实施情况,及早发现吸烟“失误”,并使治疗人员迅速作出反应。控制。剩余的参与者(n=200)将从第26周开始每月接到电话支持电话。拟议的研究将解决我们在有效戒烟治疗知识方面的几个重要空白。首先,这将是调查延长戒烟治疗效果的为数不多的研究之一。其次,这将是第一批检验多成分治疗效果的对照研究,包括药物治疗、强化行为技能培训、自助技能培训以及通过语音邮件、手机和电话咨询快速检测和反应的方法。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention.
- DOI:10.1016/j.tics.2014.02.010
- 发表时间:2014-05
- 期刊:
- 影响因子:19.9
- 作者:Ioannidis, John P. A.;Munafo, Marcus R.;Fusar-Poli, Paolo;Nosek, Brian A.;David, Sean P.
- 通讯作者:David, Sean P.
Extended treatment for cigarette smoking cessation: a randomized control trial.
戒烟的延长治疗:一项随机对照试验。
- DOI:10.1111/add.13806
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Laude,JenniferR;Bailey,SteffaniR;Crew,Erin;Varady,Ann;Lembke,Anna;McFall,Danielle;Jeon,Anna;Killen,Diana;Killen,JoelD;David,SeanP
- 通讯作者:David,SeanP
Potential reporting bias in fMRI studies of the brain.
- DOI:10.1371/journal.pone.0070104
- 发表时间:2013
- 期刊:
- 影响因子:3.7
- 作者:David SP;Ware JJ;Chu IM;Loftus PD;Fusar-Poli P;Radua J;Munafò MR;Ioannidis JP
- 通讯作者:Ioannidis JP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEAN P. DAVID其他文献
SEAN P. DAVID的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEAN P. DAVID', 18)}}的其他基金
Exploratory/Developmental Study of Pharmacogenetic Smoking Cessation Therapy
药物遗传学戒烟疗法的探索性/发展性研究
- 批准号:
7782802 - 财政年份:2009
- 资助金额:
$ 51.58万 - 项目类别:
Exploratory/Developmental Study of Pharmacogenetic Smoking Cessation Therapy
药物遗传学戒烟疗法的探索性/发展性研究
- 批准号:
7845112 - 财政年份:2009
- 资助金额:
$ 51.58万 - 项目类别:
Primary Care Genetics Cancer Prevention Conference
初级保健遗传学癌症预防会议
- 批准号:
6652383 - 财政年份:2003
- 资助金额:
$ 51.58万 - 项目类别:
Psychobiological /Genetic Determinants-Smoking Cessation
心理生物学/遗传决定因素——戒烟
- 批准号:
6582643 - 财政年份:2002
- 资助金额:
$ 51.58万 - 项目类别:
Psychobiological /Genetic Determinants-Smoking Cessation
心理生物学/遗传决定因素——戒烟
- 批准号:
6937777 - 财政年份:2002
- 资助金额:
$ 51.58万 - 项目类别:
Psychobiological /Genetic Determinants-Smoking Cessation
心理生物学/遗传决定因素——戒烟
- 批准号:
6800391 - 财政年份:2002
- 资助金额:
$ 51.58万 - 项目类别:
Psychobiological /Genetic Determinants-Smoking Cessation
心理生物学/遗传决定因素——戒烟
- 批准号:
7106368 - 财政年份:2002
- 资助金额:
$ 51.58万 - 项目类别:
相似海外基金
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
- 批准号:
10577022 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
A Controlled Study of Extended Cannabis Abstinence in Major Depression
重度抑郁症患者长期吸食大麻的对照研究
- 批准号:
478313 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Operating Grants
Exercised-induced modulation of insular cortex microcircuitry during alcohol abstinence
戒酒期间运动诱导的岛叶皮质微电路调节
- 批准号:
10748763 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
Prapela™ SVS:一种经济高效的随机振动触觉刺激装置,可改善患有新生儿戒断综合征的婴儿的临床过程。
- 批准号:
10837421 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Enforced alcohol abstinence: does it reduce reoffending?
强制戒酒:会减少再犯罪吗?
- 批准号:
ES/X003566/1 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Fellowship
Neurobiological impact of acute digital media abstinence among drug using college students
吸毒大学生急性数字媒体戒断的神经生物学影响
- 批准号:
10677380 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Single-cell whole brain imaging of nicotine intoxication, dependence, and abstinence
尼古丁中毒、依赖和戒断的单细胞全脑成像
- 批准号:
10588509 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Understanding recovery from alcohol use disorder: Longitudinal observation of two voluntary temporary abstinence periods
了解酒精使用障碍的恢复:两个自愿临时戒酒期的纵向观察
- 批准号:
10740677 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Sleep Disturbances During Cocaine Abstinence, Dopamine Adaptations, and Motivation for Cocaine
可卡因戒断期间的睡眠障碍、多巴胺适应和可卡因动机
- 批准号:
10681668 - 财政年份:2023
- 资助金额:
$ 51.58万 - 项目类别:
Relationship of autonomic nervous system function on functional brain networks during normal drinking and abstinence in daily drinkers
日常饮酒者正常饮酒和戒酒时自主神经系统功能与功能性脑网络的关系
- 批准号:
10540603 - 财政年份:2022
- 资助金额:
$ 51.58万 - 项目类别: